CellSource, Nov-Jan (1Q) Ordinary Profit Turns to Loss

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Tue Mar 11, 2025 3:30 pm JST Earnings

4880 CellSource Co., Ltd. 【J-GAAP】

Earnings Report

CellSource Co., Ltd. <4880> [TSE Prime] announced its financial results after the market closed on March 11th (15:30). The consolidated ordinary profit/loss for the first quarter of the fiscal year ending October 2025 (November 2024 to January 2025) turned into a loss of 60 million yen (compared to a profit of 208 million yen in the previous period non-consolidated).

In the most recent three-month period, from November to January (1Q), the operating profit/loss margin drastically worsened from 17.5% in the same period last year to -7.3%.

Note: Since the current fiscal year, the company has transitioned to consolidated financial statements.

Kabutan News

Actual Results

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Nov - Jan, 2022	1,059	351	334	216	11.6	51.4	Mar 14, 2023	J-GAAP
Nov - Jan, 2023	1,173	205	208	143	7.3	53.6	Mar 11, 2024	J-GAAP
Nov - Jan, 2024	849	-62	-60	-45	-2.3	ー	Mar 11, 2025	J-GAAP
YoY	-27.6%	－	－	－	－

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Nov - Apr, 2023	2,227	281	388	299	15.2	0	Jun 13, 2024	J-GAAP
Nov - Apr, 2024 Guidance	ー	ー	ー	ー	－	0	Dec 12, 2024	J-GAAP
YoY	－	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct, 2023	4,510	1,221	1,194	923	48.9	20	Dec 15, 2023	J-GAAP
Oct, 2024	4,355	129	236	237	12.0	5	Dec 12, 2024	J-GAAP
Oct, 2025 Guidance	4,501	370	372	255	12.9	5	Dec 12, 2024	J-GAAP
YoY	+3.4%	+186.8%	+57.6%	+7.6%	+7.1%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Nov - Jan, 2023	1,173	205	208	143	7.3	17.5	Mar 11, 2024	J-GAAP
Feb - Apr, 2024	1,054	76	180	156	7.9	7.2	Jun 13, 2024	J-GAAP
May - Jul, 2024	1,114	107	107	75	3.8	9.6	Sep 12, 2024	J-GAAP
Aug - Oct, 2024	1,014	-259	-259	-137	-7.0	-25.5	Dec 12, 2024	J-GAAP
Nov - Jan, 2024	849	-62	-60	-45	-2.3	-7.3	Mar 11, 2025	J-GAAP
YoY	-27.6%	－	－	－	－